Given navitoclax’s high selectivity for Bcl-2 and Bcl-xL and venetoclax’s high selectivity for Bcl-2, these results highlight the importance of Mcl-1 in GBM cell survival. The gene discussed is BCL2; the disease is glioblastoma.